CU Anschutz study shows CAR T‑cell therapy improves Stiff Person Syndrome

A recent study conducted at CU Anschutz in Aurora reports that CAR T‑cell therapy yields lasting improvements for patients with Stiff Person Syndrome, a rare neurological condition. The research, carried out in the campus’s research facilities, indicates that patients experienced sustained symptom relief after receiving the therapy. While the study offers promise, it suggests further research is needed to establish the therapy’s broader effectiveness for this uncommon ailment.